March 25 (Reuters) - Xspray Pharma AB (publ) XSPRAY.ST:
SAID ON TUESDAY IT HAD RESOLVED ON RIGHTS ISSUE OF ABOUT SEK 83 MILLION WITH OVER-ALLOTMENT ISSUE
RIGHTS ISSUE COULD BE INCREASED WITH UP TO SEK 20 MILLION AS OVER-ALLOTMENT ISSUE
SUBSCRIPTION PRICE OF SEK 20 PER SHARE
SUBSCRIPTION PERIOD IS EXPECTED TO RUN FROM 7 APRIL 2026 UP TO AND INCLUDING 21 APRIL 2026
Source text for Workspace: nMFN6Xf9lG
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))